Irisin in humans: Recent advances and questions for future research

Metabolism: Clinical and Experimental

Volumn 63, Issue 2, 2014, Pages 178-180

  Boström, Pontus A ^a   Fernández Real, José Manuel ^b,c   Mantzoros, Christos ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Hospital of Girona   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; IRISIN; LIPID; MEMBRANE PROTEIN; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD LEVEL; BODY WEIGHT; CELL CULTURE; DIABETES MELLITUS; DIABETIC PATIENT; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; INFLAMMATION; LIPID BLOOD LEVEL; MOUSE; MUSCLE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; WESTERN BLOTTING;

ANIMALS; BIOMEDICAL RESEARCH; BODY MASS INDEX; DIMERIZATION; FATTY LIVER; FIBRONECTINS; HUMANS; MICE; MUSCLE, SKELETAL; OBESITY;

EID: 84892676533     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.11.009     Document Type: Editorial

References (26)

1. J. Wu, P. Bostrom, and L.M. Sparks et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human Cell 150 2 2012 366 376
2. P. Bostrom, J. Wu, and M.P. Jedrychowski et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis Nature 481 7382 2012 463 468
3. T. Shan, X. Liang, and P. Bi et al. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle FASEB J 27 5 2013 1981 1989
4. Y. Zhang, R. Li, and Y. Meng et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling Diabetes 2013 [Epub ahead of print]
5. C.D. Wrann, J.P. White, and J. Salogiannnis et al. Exercise induces hippocampal bdnf through a PGC-1alpha/Fndc5 pathway Cell Metab 18 5 2013 649 659 http://dx.doi.org/10.1016/j.cmet.2013.09.008. [Epub 2013 Oct 10].
6. I. Gouni-Berthold, H.K. Berthold, and J.Y. Huh et al. Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo PLoS One 8 9 2013 e72858 10.1371/journal.pone.0072858
7. J.M. Moreno-Navarrete, F. Ortega, and M. Serrano et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance J Clin Endocrinol Metab 98 4 2013 E769 E778
8. S. Aydin, S. Aydin, and T. Kuloglu et al. Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running Peptides 50 2013 13 18 http://dx.doi.org/10.1016/j.peptides.2013.09.011. [Epub 2013 Oct 1].
9. R.R. Kraemer, P. Shockett, and N.D. Webb et al. A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women Horm Metab Res 2013 [Epub ahead of print]
10. J.Y. Huh, G. Panagiotou, and V. Mougios et al. Fndc5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise Metabolism 61 12 2012 1725 1738
11. S.H. Lecker, A. Zavin, and P. Cao et al. Expression of the irisin precursor Fndc5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure Circ Heart Fail 5 6 2012 812 818
12. S. Pekkala, P. Wiklund, and J.J. Hulmi et al. Are skeletal muscle Fndc5 gene expression and irisin release regulated by exercise and related to health? J Physiol 591 Pt 21 2013 5393 5400 http://dx.doi.org/10.1113/jphysiol.2013. 263707. [Epub 2013 Sep 2].
13. S. Raschke, M. Elsen, and H. Gassenhuber et al. Evidence against a beneficial effect of irisin in humans PLoS One 8 9 2013 e73680 10.1371/journal.pone.0073680
14. C. Moraes, V.O. Leal, and S.M. Marinho et al. Resistance exercise training does not affect plasma irisin levels of hemodialysis patients Horm Metab Res 45 12 2013 900 904 http://dx.doi.org/10.1055/s-0033-1354402. [Epub 2013 Sep 6].
15. M.A. Schumacher, N. Chinnam, and T. Ohashi et al. Structure of irisin reveals a novel intersubunit beta-sheet fibronectin (FNIII) dimer; implications for receptor activation J Biol Chem 288 47 2013 33738 33744 http://dx.doi.org/ 10.1074/jbc.M113.516641. [Epub 2013 Oct 10].
16. S.A. Polyzos, J. Kountouras, and A.D. Anastasilakis et al. Irisin in patients with nonalcoholic fatty liver disease Metabolism 63 2013 178 180
17. K.H. Park, L. Zaichenko, and M. Brinkoetter et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome J Clin Endocrinol Metab 2013 [Epub ahead of print]
18. H.J. Zhang, X.F. Zhang, and Z.M. Ma et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults J Hepatol 59 3 2013 557 562 http://dx.doi.org/10.1016/j.jhep.2013.04.030. [Epub 2013 May 9].
19. A. Stengel, T. Hofmann, and M. Goebel-Stengel et al. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity - correlation with body mass index Peptides 39 2013 125 130
20. J.J. Liu, M.D. Wong, and W.C. Toy et al. Lower circulating irisin is associated with type 2 diabetes mellitus J Diabetes Complications 27 4 2013 365 369
21. Y.K. Choi, M.K. Kim, and K.H. Bae et al. Serum irisin levels in new-onset type 2 diabetes Diabetes Res Clin Pract 100 1 2013 96 101
22. H.P. Erickson Irisin and Fndc5 in retrospect: an exercise hormone or a transmembrane receptor? Adipocyte 2 4 2013 289 293
23. I.P. Ivanov, A.E. Firth, and A.M. Michel et al. Identification of evolutionarily conserved non-aug-initiated n-terminal extensions in human coding sequences Nucleic Acids Res 39 10 2011 4220 4234
24. H.J. Zhang, X.F. Zhang, and Z.M. Ma et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults J Hepatol 59 3 2013 557 562
25. M.S. Wen, C.Y. Wang, and S.L. Lin et al. Decrease in irisin in patients with chronic kidney disease PLoS One 8 5 2013 e64025 http://dx.doi.org/10.1371/ journal.pone.0064025. [Print 2013].
26. M.T. Vamvini, K.N. Aronis, and G. Panagiotou et al. Irisin mrna and circulating levels in relation to other myokines in healthy and morbidly obese humans Eur J Endocrinol 169 6 2013 829 834